How about shifting the reliance on medicare funding for GME (residency/fellowship) to private inititiaves such as hospital funded...

eGenesis, a biotech company based out of Cambridge, MA along with a group of surgeon/physician scientists at Massachusetts General...

Should Metformin remain as the first line agent for oral treatment of T2DM?  NYTimes piece sheds some light on how Metformin is being...

Agree with the WSJ authors who are also physicians at Yale School of Medicine: "To make this revolution a reality, the U.S. needs a...

Watch out for Eli Lilly's Orforglipron- though the official trial data needs to be seen, based on early reports and as described in...

The prospective study showed comparable proportion of living kidney donors and nondonors to develop hypertension (17%) over a follow up...

Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2...